Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Combined heart and liver transplantation: A single-center experience
Eugenia Raichlin
, Richard C. Daly
, Charles B. Rosen
,
Christopher G. McGregor
, Michael R. Charlton
, Robert P. Frantz
, Alfredo L. Clavell
, Richard J. Rodeheffer
, Naveen L. Pereira
, Walter K. Kremers
, Sudhir S. Kushwaha
, Brooks S. Edwards
Research output
:
Contribution to journal
›
Article
›
peer-review
124
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combined heart and liver transplantation: A single-center experience'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Liver Transplantation
100%
Heart Transplantation
100%
Single-center Experience
100%
Isolated Heart
40%
Cardiac Cirrhosis
40%
Mayo Clinic
20%
Cardiac Allograft Rejection
20%
Calcineurin
20%
Metabolic Disorders
20%
Congenital Heart Disease
20%
Hemodynamically Unstable
20%
Stable Patients
20%
Left Ventricular Ejection Fraction
20%
Pretransplant
20%
Patient Selection
20%
Hemochromatosis
20%
Lifesaving
20%
Changes with Time
20%
Survival Rate
20%
Primary Biliary Cirrhosis
20%
Combined Procedure
20%
Nephrotoxicity
20%
Postoperative Mortality
20%
Orthotopic Heart Transplantation
20%
Restrictive Cardiomyopathy
20%
End-stage Liver Disease
20%
Orthotopic Liver Transplantation
20%
End-stage Renal Failure
20%
End-stage Heart Disease
20%
Primary Pulmonary Hypertension
20%
Heart-lung Transplantation
20%
ISHLT
20%
Familial Amyloidosis
20%
Cardiac Diagnosis
20%
Heart-liver Transplantation
20%
Heart-kidney Transplantation
20%
Combined Heart-liver Transplantation
20%
Liver Allograft Function
20%
Medicine and Dentistry
Liver Transplantation
100%
Heart Transplantation
100%
Liver Cirrhosis
28%
Isolated Heart
28%
Persistent Truncus Arteriosus
14%
Pulmonary Hypertension
14%
Allograft
14%
Kidney Transplantation
14%
End Stage Renal Disease
14%
Heart Left Ventricle Ejection Fraction
14%
Liver Disease
14%
Primary Biliary Cirrhosis
14%
Survival Rate
14%
Restrictive Cardiomyopathy
14%
Cardiac Graft Rejection
14%
Heart Lung Transplantation
14%
Familial Amyloidosis
14%
Heart Disease
14%
Metabolic Disorder
14%
Hemochromatosis
14%
Nephrotoxicity
14%
Calcineurin
14%